Stock Price
82.92
Daily Change
0.60 0.73%
Monthly
5.18%
Yearly
-31.33%
Q3 Forecast
81.68

Symrise reported EUR1.24B in Sales Revenues for its fiscal semester ending in September of 2025.




Sales Change Date
Avient USD 866.5M 39.5M Jun/2025
Chemours USD 1.62B 250M Jun/2025
Corteva USD 6.54B 1.93B Jun/2025
Covestro EUR 3.38B 90M Jun/2025
Symrise EUR 1.24B 80M Sep/2025
Victrex 145.9M 68.2M Mar/2025